FDA Approves Minimally Invasive Sacroiliac Joint Fusion Technique Developed by East Texas Surgeon
核心洞察
Dr. Babajide Ogunseinde received FDA approval for a novel posterior medial to lateral technique to treat sacroiliac joint dysfunction (搜索), offering a less invasive option.
The procedure involves a small 2 cm incision and a 3D-printed implant to stabilize and fuse the sacroiliac joints, minimizing soft tissue trauma and blood loss.
Benefits include earlier pain relief, no weight-bearing restrictions post-surgery, and a quick recovery, allowing patients to resume normal activities within days.
Longview, TX - The U.S. Food and Drug Administration (FDA) has approved a new minimally invasive surgical technique for sacroiliac (SI) joint fusion, developed by Dr. Babajide Ogunseinde, an orthopedic spine surgeon at Longview Orthopedics Regional Clinics in East Texas. This innovative posterior medial to lateral approach offers a less invasive alternative for patients suffering from lower back pain due to sacroiliac joint dysfunction (搜索).
Minimally Invasive Approach
Dr. Ogunseinde's technique distinguishes itself from traditional methods by utilizing a single, small 2-centimeter incision. "There are many other techniques that have been published in the spine literature about circular fusion and those involve multiple incisions, longer surgeries," Ogunseinde said. "They're more painful... So this procedure that we started at Longview Regional was inspired by looking for a way to reduce those factors, the pain, the bleeding, the multiple incisions."
The procedure addresses bilateral sacroiliac dysfunction in a single surgery, minimizing soft tissue trauma and blood loss. According to Longview Regional Medical Center, the technology incorporates a specially designed, 3D-printed implant to stabilize and fuse the SI joints, effectively limiting excessive motion.
Improved Patient Outcomes
One of the key advantages of this new technique is the rapid recovery time and reduced post-operative restrictions. "Through this technology, there has been earlier pain relief post-surgery with no weight bearing restrictions after the operation, which offers an improved quality of life when other options have been unsuccessful," Ogunseinde noted.
Patients typically go home the same day on oral pain medication and can shower and drive within one to two days. The anesthesia lasts approximately 20-25 minutes, with a recovery period of about 30 minutes. Patients have reported feeling significantly better within a few days post-surgery.
Addressing Sacroiliac Joint Dysfunction
Sacroiliac joint dysfunction (搜索) is estimated to be the cause of lower back pain in approximately 30% of patients. Risk factors include being female, overweight, having multiple children, or experiencing trauma to the pelvis or SI joint. "So 10 to 15, years ago, when we didn't know anything about SI joint dysfunction, we just thought patients were not being honest or felt like they had some psychosomatic problems. But now that we know that SI joint is a problem, especially for low back pain... We've had so much success with identifying this and treating this either non-surgically and surgically," Ogunseinde explained.
This FDA-approved procedure represents a significant advancement in the treatment of sacroiliac joint dysfunction (搜索), offering a minimally invasive option with the potential for faster recovery and improved quality of life for patients.